Legfrissebb próbák

EudraCT Number: 2004-000933-12

Sponsor Protocol Number: AX-CL-10

Start Date: 2005-02-22

Sponsor Name: Axonyx Inc

Full Title: A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of phenserine-tartrate in patients with probable mild to moderate Alzheimer’s disease

Medical condition: Alzheimers disease is caused by a loss of nerve cells in the brain, particularly in the areas associated with memory and learning. The onset of Alzheimers's also affects the levels of a certain neu...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-002934-20

Sponsor Protocol Number: M04-691

Start Date: 2005-02-22

Sponsor Name: Abbott GmbH & Co. KG

Full Title: A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Moderate to Severe C...

Medical condition: Crohn's Disease

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

EudraCT Number: 2004-002030-19

Sponsor Protocol Number: ABCSG-24

Start Date: 2005-02-22

Sponsor Name: AUSTRIAN BREAST CANCER STUDY GROUP

Full Title: A randomized phase III study comparing epirubicin, docetaxel and capecitabine + G-CSF to epirubicin and docetaxel + G-CSF as neoadjuvant treatment for early HER-2 negative breast cancer and compari...

Medical condition: early HER-2 breast cancer

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: AT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001749-13

Sponsor Protocol Number: P04071

Start Date: 2005-02-22

Sponsor Name: AESCA Pharma GesmbH

Full Title: Randomized Phase II Study: Temozolomide (TMZ) Concomitant to Radiotherapy followed by sequential TMZ in Advanced NSCLC Patients with CNS Metastasis versus Radiotherapy alone

Medical condition: Patients with non small cell lung cancer (NSCLC) have a high risk of developing brain metastasis, up to 40% as evaluated in autopsy studies. These patients are often heavily symptomatic and their l...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-000202-49

Sponsor Protocol Number: CN138-134

Start Date: 2005-02-22

Sponsor Name: Bristol-Myers Squibb International Corporation

Full Title: Efficacy of Aripiprazole in Combination with Valproate or Lithium in the Treatment of Mania in Patients with Bipolar I Disorder Partially Nonresponsive to Valproate or Lithium Monotherapy Revised...

Medical condition: Bipolar disorder

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: EE (Completed) HU (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2005-000728-18

Sponsor Protocol Number: VT002

Start Date: 2005-02-21

Sponsor Name: AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE

Full Title: An experiment of phase II open label about safety and Mifepristone vgx-410 anti-HIV activity on patients affected by HIV-1

Medical condition: Anti-HIV drug

Disease:	Version	SOC Term	Classification Code	Term	Level
			10000807		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004269-14

Sponsor Protocol Number: A5091026

Start Date: 2005-02-21

Sponsor Name: Pfizer AB

Full Title: Phase 3, Multi-center, double-blind, randomized, parallel group study of the efficacy, safety, and tolerability of fixed combination torcetrapib (CP-529,414)/Atorvastatin administered orally, once ...

Medical condition: Heterozygous Familial Hypercholesterolemia

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10057079		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) DK (Completed) IS (Completed)

Trial results: View results

EudraCT Number: 2004-002208-14

Sponsor Protocol Number: Protocol v.1.2 30/08/04

Start Date: 2005-02-21

Sponsor Name: Cardiff and Vale NHS Trust

Full Title: Duration of Amiodarone therapy required for new post cardiac surgery atrial fibrillation.

Medical condition: Atrial fibrillation following cardiac surgery.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-004267-30

Sponsor Protocol Number: Gebro-III-21-10

Start Date: 2005-02-21

Sponsor Name: Gebro Pharma GmbH

Full Title: Efficacy and Tolerability of Dexibuprofen Film coated tablets in Comparison to Ibuprofen in Children and Adolescents with Tonsillopharyngitis

Medical condition: Tonsillopharyngitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2004-004748-27

Sponsor Protocol Number: Acadmed CTU01/05

Start Date: 2005-02-21

Sponsor Name: Hull and east Yorkshire Hospitals Trust, Research and Deveopment, admin porta cabin

Full Title: An 8 week, double-blind, randomised, parallel group study to investigate the effect of 20 mg Esomeprazole (Nexium) tablets Twice daily versus placebo on symptoms associated with chronic cough due ...

Medical condition: We will be using Nexium to treat gastro-oesophageal reflux and in return this will reduce reflux related cough ( a manifestation of reflux)

Disease:	Version	SOC Term	Classification Code	Term	Level
	3		10013946		2

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

Legfrissebb próbák

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások